{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T02:42:19Z","timestamp":1794883339789,"version":"4.9.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20361"],"award-info":[{"award-number":["U21A20361"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Molecular Autism"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Fragile X syndrome (FXS) is a leading cause of autism spectrum disorder (ASD) and resulted from a loss of the <jats:italic>FMR1<\/jats:italic>-encoded fragile X messenger ribonucleoprotein 1 (FMRP) protein due to large CGG repeat expansions in the promoter region of the <jats:italic>FMR1<\/jats:italic> gene. The microtubule-associated protein Tau is a promising target for Tauopathic diseases and our preliminary study found that Tau protein levels were increased in the brain of <jats:italic>Fmr1<\/jats:italic> knockout (KO) mice, a model of FXS. However, whether Tau reduction can prevent autism-like features in <jats:italic>Fmr1<\/jats:italic> KO mice and become a novel strategy for FXS treatment remain unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Tau was genetically reduced in <jats:italic>Fmr1<\/jats:italic> KO mice through crossing <jats:italic>Fmr1<\/jats:italic><jats:sup>\u00b1<\/jats:sup> female mice with <jats:italic>Mapt<\/jats:italic><jats:sup>\u00b1<\/jats:sup> male mice. The male offspring with different genotypes were subjected to various autism-related behavioral tests, RNA sequencing, and biochemical analysis. <jats:italic>Fmr1<\/jats:italic> KO male mice were treated with Tau-targeting antisense oligonucleotide (ASO) and then subjected to behavioral tests and biochemical analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Tau expression was increased in the cortex of <jats:italic>Fmr1<\/jats:italic> KO mice. Genetically reducing Tau prevented social defects, stereotyped and repetitive behavior, and spine abnormality in <jats:italic>Fmr1<\/jats:italic> KO mice. Tau reduction also reversed increased periodic activity and partially rescued <jats:italic>Per1<\/jats:italic> expression reduction in <jats:italic>Fmr1<\/jats:italic> KO mice. Moreover, Tau reduction reversed compromised P38\/MAPK signaling in <jats:italic>Fmr1<\/jats:italic> KO mice. Finally, Tau-targeting ASO also effectively alleviated autism-like phenotypes and promoted P38\/MAPK signaling in <jats:italic>Fmr1<\/jats:italic> KO mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Limitations<\/jats:title>\n                <jats:p>Our study is limited to male mice, in agreement with the higher incidence of FXS in males than females. Whether Tau reduction also exerts protection in females deserves further scrutiny. Moreover, although Tau reduction rescues impaired P38\/MAPK signaling in <jats:italic>Fmr1<\/jats:italic> KO mice, whether this is the responsible molecular mechanism requires further determination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our data indicate that Tau reduction prevents autism-like phenotypes in <jats:italic>Fmr1<\/jats:italic> KO mice. Tau may become a new target for FXS treatment.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13229-023-00574-1","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T11:02:14Z","timestamp":1699354934000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Tau reduction attenuates autism-like features in Fmr1 knockout mice"],"prefix":"10.1186","volume":"14","author":[{"given":"Shanshan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linkun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"574_CR1","doi-asserted-by":"publisher","first-page":"17065","DOI":"10.1038\/nrdp.2017.65","volume":"3","author":"RJ Hagerman","year":"2017","unstructured":"Hagerman RJ, Berry-Kravis E, Hazlett HC, Bailey DB, Moine H, Kooy RF, Tassone F, Gantois I, Sonenberg N, Mandel JL, et al. Fragile X syndrome. Nat Rev Dis Primers. 2017;3:17065.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"574_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ajmg.a.38504","volume":"176","author":"AF Sitzmann","year":"2018","unstructured":"Sitzmann AF, Hagelstrom RT, Tassone F, Hagerman RJ, Butler MG. Rare FMR1 gene mutations causing fragile X syndrome: a review. Am J Med Genet A. 2018;176(1):11\u20138.","journal-title":"Am J Med Genet A"},{"issue":"6","key":"574_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1515\/revneuro-2014-0056","volume":"25","author":"S Bhat","year":"2014","unstructured":"Bhat S, Acharya UR, Adeli H, Bairy GM, Adeli A. Autism: cause factors, early diagnosis and therapies. Rev Neurosci. 2014;25(6):841\u201350.","journal-title":"Rev Neurosci"},{"key":"574_CR4","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2018.12.005","volume":"175","author":"C Tapia-Rojas","year":"2019","unstructured":"Tapia-Rojas C, Cabezas-Opazo F, Deaton CA, Vergara EH, Johnson GVW, Quintanilla RA. It\u2019s all about tau. Prog Neurobiol. 2019;175:54\u201376.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"574_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-022-00533-z","volume":"17","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wu KM, Yang L, Dong Q, Yu JT. Tauopathies: new perspectives and challenges. Mol Neurodegener. 2022;17(1):28.","journal-title":"Mol Neurodegener"},{"issue":"12","key":"574_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"C Li","year":"2017","unstructured":"Li C, Gotz J. Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov. 2017;16(12):863\u201383.","journal-title":"Nat Rev Drug Discov"},{"issue":"642","key":"574_CR7","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1126\/scitranslmed.abm5527","volume":"14","author":"E Shao","year":"2022","unstructured":"Shao E, Chang CW, Li ZY, Yu XX, Ho K, Zhang M, Wang X, Simms J, Lo I, Speckart J, et al. TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model. Sci Transl Med. 2022;14(642):5527.","journal-title":"Sci Transl Med."},{"issue":"3","key":"574_CR8","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.neuron.2020.01.038","volume":"106","author":"C Tai","year":"2020","unstructured":"Tai C, Chang CW, Yu GQ, Lopez I, Yu XX, Wang X, Guo WK, Mucke L. Tau reduction prevents key features of autism in mouse models. Neuron. 2020;106(3):421\u201337.","journal-title":"Neuron"},{"issue":"3","key":"574_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1002\/ana.24230","volume":"76","author":"AL Gheyara","year":"2014","unstructured":"Gheyara AL, Ponnusamy R, Djukic B, Craft RJ, Ho K, Guo W, Finucane MM, Sanchez PE, Mucke L. Tau reduction prevents disease in a mouse model of Dravet syndrome. Ann Neurol. 2014;76(3):443\u201356.","journal-title":"Ann Neurol"},{"issue":"3","key":"574_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.neuron.2020.04.019","volume":"106","author":"ME Modi","year":"2020","unstructured":"Modi ME, Sahin M. Tau: a novel entry point for mTOR-based treatments in autism spectrum disorder? Neuron. 2020;106(3):359\u201361.","journal-title":"Neuron"},{"issue":"3","key":"574_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13238-021-00878-z","volume":"13","author":"C Yang","year":"2022","unstructured":"Yang C, Tian Y, Su F, Wang Y, Liu M, Wang H, Cui Y, Yuan P, Li X, Li A, et al. Restoration of FMRP expression in adult V1 neurons rescues visual deficits in a mouse model of fragile X syndrome. Protein Cell. 2022;13(3):203\u201319.","journal-title":"Protein Cell"},{"issue":"2","key":"574_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nm.2613","volume":"18","author":"P Lei","year":"2012","unstructured":"Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, Adlard PA, Cherny RA, Lam LQ, et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat Med. 2012;18(2):291\u20135.","journal-title":"Nat Med"},{"key":"574_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.lfs.2015.10.025","volume":"152","author":"S Dutta","year":"2016","unstructured":"Dutta S, Sengupta P. Men and mice: relating their ages. Life Sci. 2016;152:244\u20138.","journal-title":"Life Sci"},{"issue":"3","key":"574_CR14","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.biopsych.2018.08.009","volume":"86","author":"DD Zhao","year":"2019","unstructured":"Zhao DD, Meng J, Zhao YJ, Huo YH, Liu Y, Zheng NZ, Zhang MX, Gao Y, Chen ZC, Sun H, et al. RPS23RG1 is required for synaptic integrity and rescues Alzheimer\u2019s disease-associated cognitive deficits. Biol Psychiat. 2019;86(3):171\u201384.","journal-title":"Biol Psychiat"},{"issue":"25","key":"574_CR15","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1523\/JNEUROSCI.1644-21.2022","volume":"42","author":"J Meng","year":"2022","unstructured":"Meng J, Han L, Zheng N, Wang T, Xu H, Jiang Y, Wang Z, Liu Z, Zheng Q, Zhang X, et al. Microglial Tmem59 deficiency impairs phagocytosis of synapse and leads to autism-like behaviors in mice. J Neurosci. 2022;42(25):4958\u201379.","journal-title":"J Neurosci"},{"key":"574_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.669798","volume":"9","author":"M Zhang","year":"2021","unstructured":"Zhang M, Zhou Y, Jiang Y, Lu Z, Xiao X, Ning J, Sun H, Zhang X, Luo H, Can D, et al. Profiling of sexually dimorphic genes in neural cells to identify Eif2s3y, whose overexpression causes autism-like behaviors in male mice. Front Cell Dev Biol. 2021;9: 669798.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"574_CR17","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/nprot.2006.170","volume":"1","author":"RM Deacon","year":"2006","unstructured":"Deacon RM. Assessing nest building in mice. Nat Protoc. 2006;1(3):1117\u20139.","journal-title":"Nat Protoc"},{"issue":"7033","key":"574_CR18","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/nature03453","volume":"434","author":"Y Xu","year":"2005","unstructured":"Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptacek LJ, Fu YH. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 2005;434(7033):640\u20134.","journal-title":"Nature"},{"issue":"1","key":"574_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.11.043","volume":"128","author":"Y Xu","year":"2007","unstructured":"Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptacek LJ. Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell. 2007;128(1):59\u201370.","journal-title":"Cell"},{"issue":"1","key":"574_CR20","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1038\/s41467-019-11513-1","volume":"10","author":"S Chen","year":"2019","unstructured":"Chen S, Feng M, Zhang S, Dong Z, Wang Y, Zhang W, Liu C. Angptl8 mediates food-driven resetting of hepatic circadian clock in mice. Nat Commun. 2019;10(1):3518.","journal-title":"Nat Commun"},{"issue":"31","key":"574_CR21","doi-asserted-by":"publisher","first-page":"12887","DOI":"10.1523\/JNEUROSCI.2107-13.2013","volume":"33","author":"SL DeVos","year":"2013","unstructured":"DeVos SL, Goncharoff DK, Chen G, Kebodeaux CS, Yamada K, Stewart FR, Schuler DR, Maloney SE, Wozniak DF, Rigo F, et al. Antisense reduction of tau in adult mice protects against seizures. J Neurosci. 2013;33(31):12887\u201397.","journal-title":"J Neurosci"},{"issue":"8","key":"574_CR22","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1172\/JCI25424","volume":"116","author":"RA Smith","year":"2006","unstructured":"Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TF, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei HB, et al. Antisense oligonucleotide therapy for neurodegenerative disease. J Clin Invest. 2006;116(8):2290\u20136.","journal-title":"J Clin Invest"},{"issue":"4","key":"574_CR23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/dneu.22417","volume":"77","author":"V Martinez-Cerdeno","year":"2017","unstructured":"Martinez-Cerdeno V. Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models. Dev Neurobiol. 2017;77(4):393\u2013404.","journal-title":"Dev Neurobiol"},{"issue":"41","key":"574_CR24","doi-asserted-by":"publisher","first-page":"17768","DOI":"10.1073\/pnas.1012496107","volume":"107","author":"F Pan","year":"2010","unstructured":"Pan F, Aldridge GM, Greenough WT, Gan WB. Dendritic spine instability and insensitivity to modulation by sensory experience in a mouse model of fragile X syndrome. Proc Natl Acad Sci USA. 2010;107(41):17768\u201373.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"23","key":"574_CR25","doi-asserted-by":"publisher","first-page":"7793","DOI":"10.1523\/JNEUROSCI.0577-10.2010","volume":"30","author":"A Cruz-Martin","year":"2010","unstructured":"Cruz-Martin A, Crespo M, Portera-Cailliau C. Delayed stabilization of dendritic spines in fragile X mice. J Neurosci. 2010;30(23):7793\u2013803.","journal-title":"J Neurosci"},{"issue":"5","key":"574_CR26","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nrn1667","volume":"6","author":"C Bagni","year":"2005","unstructured":"Bagni C, Greenough WT. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Nat Rev Neurosci. 2005;6(5):376\u201387.","journal-title":"Nat Rev Neurosci"},{"key":"574_CR27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1101\/sqb.2007.72.052","volume":"72","author":"SM Siepka","year":"2007","unstructured":"Siepka SM, Yoo SH, Park J, Lee C, Takahashi JS. Genetics and neurobiology of circadian clocks in mammals. Cold Spring Harb Symp Quant Biol. 2007;72:251\u20139.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"1","key":"574_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajhg.2008.06.003","volume":"83","author":"J Zhang","year":"2008","unstructured":"Zhang J, Fang Z, Jud C, Vansteensel MJ, Kaasik K, Lee CC, Albrecht U, Tamanini F, Meijer JH, Oostra BA, et al. Fragile X-related proteins regulate mammalian circadian behavioral rhythms. Am J Hum Genet. 2008;83(1):43\u201352.","journal-title":"Am J Hum Genet"},{"key":"574_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fnmol.2017.00280","volume":"10","author":"RM Sare","year":"2017","unstructured":"Sare RM, Harkless L, Levine M, Torossian A, Sheeler CA, Smith CB. Deficient sleep in mouse models of fragile X syndrome. Front Mol Neurosci. 2017;10:280.","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"574_CR30","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.neuron.2012.07.022","volume":"76","author":"A Bhattacharya","year":"2012","unstructured":"Bhattacharya A, Kaphzan H, Alvarez-Dieppa AC, Murphy JP, Pierre P, Klann E. Genetic removal of p70 S6 kinase 1 corrects molecular, synaptic, and behavioral phenotypes in fragile X syndrome mice. Neuron. 2012;76(2):325\u201337.","journal-title":"Neuron"},{"issue":"4","key":"574_CR31","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.neuron.2006.07.005","volume":"51","author":"L Hou","year":"2006","unstructured":"Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Neuron. 2006;51(4):441\u201354.","journal-title":"Neuron"},{"issue":"41","key":"574_CR32","doi-asserted-by":"publisher","first-page":"E6290","DOI":"10.1073\/pnas.1610812113","volume":"113","author":"K Sawicka","year":"2016","unstructured":"Sawicka K, Pyronneau A, Chao M, Bennett MV, Zukin RS. Elevated ERK\/p90 ribosomal S6 kinase activity underlies audiogenic seizure susceptibility in fragile X mice. Proc Natl Acad Sci U S A. 2016;113(41):E6290\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"574_CR33","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1073\/pnas.0800257105","volume":"105","author":"SH Kim","year":"2008","unstructured":"Kim SH, Markham JA, Weiler IJ, Greenough WT. Aberrant early-phase ERK inactivation impedes neuronal function in fragile X syndrome. Proc Natl Acad Sci U S A. 2008;105(11):4429\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"31","key":"574_CR34","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1523\/JNEUROSCI.1496-08.2008","volume":"28","author":"H Hu","year":"2008","unstructured":"Hu H, Qin Y, Bochorishvili G, Zhu Y, van Aelst L, Zhu JJ. Ras signaling mechanisms underlying impaired GluR1-dependent plasticity associated with fragile X syndrome. J Neurosci. 2008;28(31):7847\u201362.","journal-title":"J Neurosci"},{"issue":"3","key":"574_CR35","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.nbd.2011.12.037","volume":"45","author":"ZH Liu","year":"2012","unstructured":"Liu ZH, Huang T, Smith CB. Lithium reverses increased rates of cerebral protein synthesis in a mouse model of fragile X syndrome. Neurobiol Dis. 2012;45(3):1145\u201352.","journal-title":"Neurobiol Dis"},{"key":"574_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bbrc.2021.02.086","volume":"550","author":"Y Hou","year":"2021","unstructured":"Hou Y, Zhao J, Yang D, Xuan R, Xie R, Wang M, Mo H, Liang L, Wang W, Wu S, et al. LF-rTMS ameliorates social dysfunction of FMR1(-\/-) mice via modulating Akt\/GSK-3beta signaling. Biochem Biophys Res Commun. 2021;550:22\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"574_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells11081325","volume":"11","author":"C D\u2019Incal","year":"2022","unstructured":"D\u2019Incal C, Broos J, Torfs T, Kooy RF, Van den Berghe W. Towards kinase inhibitor therapies for fragile X syndrome: tweaking twists in the autism spectrum kinase signaling network. Cells. 2022;11:8.","journal-title":"Cells"},{"key":"574_CR38","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3389\/fnmol.2017.00452","volume":"10","author":"RM Sare","year":"2017","unstructured":"Sare RM, Song A, Loutaev I, Cook A, Maita I, Lemons A, Sheeler C, Smith CB. Negative effects of chronic rapamycin treatment on behavior in a mouse model of fragile X syndrome. Front Mol Neurosci. 2017;10:452.","journal-title":"Front Mol Neurosci"},{"issue":"1","key":"574_CR39","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1038\/s41467-020-16250-4","volume":"11","author":"XQ Zhan","year":"2020","unstructured":"Zhan XQ, Asmara H, Cheng N, Sahu G, Sanchez E, Zhang FX, Zamponi GW, Rho JM, Turner RW. FMRP(1\u2013297)-tat restores ion channel and synaptic function in a model of Fragile X syndrome. Nat Commun. 2020;11(1):2755.","journal-title":"Nat Commun"},{"issue":"14","key":"574_CR40","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1073\/pnas.1219383110","volume":"110","author":"BM Dolan","year":"2013","unstructured":"Dolan BM, Duron SG, Campbell DA, Vollrath B, Rao BSS, Ko HY, Lin GG, Govindarajan A, Choi SY, Tonegawa S. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. Proc Natl Acad Sci USA. 2013;110(14):5671\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"574_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.omtm.2021.06.013","volume":"22","author":"AWM Hooper","year":"2021","unstructured":"Hooper AWM, Wong H, Niibori Y, Abdoli R, Karumuthil-Melethil S, Qiao C, Danos O, Bruder JT, Hampson DR. Gene therapy using an ortholog of human fragile X mental retardation protein partially rescues behavioral abnormalities and EEG activity. Mol Ther Methods Clin Dev. 2021;22:196\u2013209.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"574_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.omtm.2022.10.002","volume":"27","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Han L, Meng J, Wang Z, Zhou Y, Yuan H, Xu H, Zhang X, Zhao Y, Lu J, et al. Gene therapy using human FMRP isoforms driven by the human FMR1 promoter rescues fragile X syndrome mouse deficits. Mol Ther Methods Clin Dev. 2022;27:246\u201358.","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6","key":"574_CR43","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.3390\/ijms22063209","volume":"22","author":"M Gassowska-Dobrowolska","year":"2021","unstructured":"Gassowska-Dobrowolska M, Kolasa-Wolosiuk A, Cieslik M, Dominiak A, Friedland K, Adamczyk A. Alterations in tau protein level and phosphorylation state in the brain of the autistic-like rats induced by prenatal exposure to valproic acid. Int J Mol Sci. 2021;22(6):3209.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"574_CR44","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1021\/pr5006372","volume":"13","author":"K Matic","year":"2014","unstructured":"Matic K, Eninger T, Bardoni B, Davidovic L, Macek B. Quantitative phosphoproteomics of murine Fmr1-KO cell lines provides new insights into FMRP-dependent signal transduction mechanisms. J Proteome Res. 2014;13(10):4388\u201397.","journal-title":"J Proteome Res"},{"issue":"1","key":"574_CR45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13041-020-00706-1","volume":"13","author":"CR Casingal","year":"2020","unstructured":"Casingal CR, Kikkawa T, Inada H, Sasaki Y, Osumi N. Identification of FMRP target mRNAs in the developmental brain: FMRP might coordinate Ras\/MAPK, Wnt\/beta-catenin, and mTOR signaling during corticogenesis. Mol Brain. 2020;13(1):167.","journal-title":"Mol Brain"}],"container-title":["Molecular Autism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-023-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13229-023-00574-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13229-023-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T12:06:55Z","timestamp":1699358815000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularautism.biomedcentral.com\/articles\/10.1186\/s13229-023-00574-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1186\/s13229-023-00574-1","relation":{},"ISSN":["2040-2392"],"issn-type":[{"value":"2040-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"assertion":[{"value":"19 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental procedures were conducted in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Animal Ethics Committee of Xiamen University (#XMULAC20220203).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}